These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17896859)
81. Continuing the evidence-based health care debate in 2006. The progress and price of EBM. Miles A; Loughlin M J Eval Clin Pract; 2006 Aug; 12(4):385-98. PubMed ID: 16907679 [No Abstract] [Full Text] [Related]
82. New policies aim to minimize potential or actual conflicts of interest. Svirsky MA Ear Hear; 2004 Apr; 25(2):85. PubMed ID: 15064653 [No Abstract] [Full Text] [Related]
83. Ethics Forum: Conflict of Interest, Part II: Pain Society Leadership and Industry. Schatman ME; Darnall BD Pain Med; 2016 Feb; 17(2):217-8. PubMed ID: 26814304 [No Abstract] [Full Text] [Related]
84. Co-ordinating 'ethical' clinical trials: the role of research coordinators in the contract research industry. Fisher JA Sociol Health Illn; 2006 Sep; 28(6):678-94. PubMed ID: 17184412 [TBL] [Abstract][Full Text] [Related]
85. [The relationship with the pharmaceutical industry: a very common ethical question in family medicine]. Altisent R Aten Primaria; 2003 Jun; 32(2):106-9. PubMed ID: 12841997 [No Abstract] [Full Text] [Related]
86. Pharmaceutical influence on clinical science and practice: a double-edged sword. Sartor RB Gastroenterology; 2004 Sep; 127(3):703-4. PubMed ID: 15362023 [No Abstract] [Full Text] [Related]
87. Publishing: The peer-review scam. Ferguson C; Marcus A; Oransky I Nature; 2014 Nov; 515(7528):480-2. PubMed ID: 25428481 [No Abstract] [Full Text] [Related]
88. Seeding trials: just say "no". Sox HC; Rennie D Ann Intern Med; 2008 Aug; 149(4):279-80. PubMed ID: 18711161 [No Abstract] [Full Text] [Related]
89. ADVANTAGE: Merck does say "no". Edelman JM Ann Intern Med; 2008 Nov; 149(10):774-5; author reply 775. PubMed ID: 19017607 [No Abstract] [Full Text] [Related]
90. ADVANTAGE: Merck does say "no". Rabin A Ann Intern Med; 2008 Nov; 149(10):774. PubMed ID: 19017608 [No Abstract] [Full Text] [Related]
91. Ethical considerations in the relationship between physicians and the pharmaceutical industry. Wazana A; Primeau F Psychiatr Clin North Am; 2002 Sep; 25(3):647-63, viii. PubMed ID: 12232977 [TBL] [Abstract][Full Text] [Related]
92. Clinical trials and the pharmaceutical industry. Rozenfeld S Cad Saude Publica; 2013 Dec; 29(12):2368-70. PubMed ID: 24356683 [No Abstract] [Full Text] [Related]
94. Publication ethics: science versus commerce. Ten Have H; Gordijn B Med Health Care Philos; 2017 Jun; 20(2):159-161. PubMed ID: 28401325 [No Abstract] [Full Text] [Related]
95. Clinical trials seen shifting overseas. Rowland C Int J Health Serv; 2004; 34(3):555-6. PubMed ID: 15346686 [TBL] [Abstract][Full Text] [Related]
96. Ninth international congress on peer review and scientific publication: call for research. Ioannidis JPA; Berkwits M; Flanagin A; Godlee F; Bloom T BMJ; 2019 Sep; 366():l5475. PubMed ID: 31527134 [No Abstract] [Full Text] [Related]
97. Institutional mistrust in the organization of pharmaceutical clinical trials. Fisher JA Med Health Care Philos; 2008 Dec; 11(4):403-13. PubMed ID: 18633728 [TBL] [Abstract][Full Text] [Related]
98. The ethics of changing practice: do we cross the line? Merry AF J Extra Corpor Technol; 2009 Dec; 41(4):P2-5. PubMed ID: 20092079 [No Abstract] [Full Text] [Related]
99. National transparency assessment of Kuwait's pharmaceutical sector. Badawi DA; Alkhamis Y; Qaddoumi M; Behbehani K Health Policy; 2015 Sep; 119(9):1275-83. PubMed ID: 26229022 [TBL] [Abstract][Full Text] [Related]
100. Recommendations on conflict of interest, including relationships with industry. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health Int J Gynaecol Obstet; 2015 Mar; 128(3):282-3. PubMed ID: 25458415 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]